Concert Pharmaceuticals
CNCE
#7193
Rank
$0.40 B
Marketcap
$8.37
Share price
0.00%
Change (1 day)
78.85%
Change (1 year)

Operating Margin for Concert Pharmaceuticals (CNCE)

Operating Margin as of January 2025 (TTM): -19,664.30%

According to Concert Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -19,664.30%. At the end of 2021 the company had an Operating Margin of -245.72%.

Operating Margin history for Concert Pharmaceuticals from 2013 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-245.72%-74.06%
2020-947.24%-86.95%
2019-7,257.75%1268.54%
2018-530.33%-900.4%
201766.26%-100.23%
2016-29,149.43%-79159.95%
201536.87%-109.97%
2014-369.62%1450.76%
2013-23.84%-85.02%
2012-159.11%173.62%
2011-58.15%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
12.95%-100.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-20.76%-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
9.98%-100.05%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-2,986.63%-84.81%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.